Thrombosis Research Journal Citation Rate 2026

ISSN 0049-3848 eISSN 1879-2472 Elsevier BV US

Q2 Quartile Established Impact

About Thrombosis Research
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Thrombosis Research (TR) is a peer-reviewed academic journal covering Antiplatelet Therapy and Cardiovascular Diseases and Blood Coagulation and Thrombosis Mechanisms, published by Elsevier BV in US, catalogued under ISSN 0049-3848 (e-ISSN 1879-2472). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.28 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4050 USD). OpenAlex records 20,312 works and 386,115 citations, with an h-index of 171.

Thrombosis Research Citation Rate 2026 — In Context

Thrombosis Research has a 2025 2-Year Citation Rate (OpenAlex) of 2.28, placing it in the Q2 quartile within the Antiplatelet Therapy and Cardiovascular Diseases research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Thrombosis Research operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Thrombosis Research should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Thrombosis Research against similar journals in the field, use our journal comparison tool.

Submission Tips for Thrombosis Research
  • Budget $4050 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Antiplatelet Therapy and Cardiovascular Diseases, Blood Coagulation and Thrombosis Mechanisms, Blood properties and coagulation. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Thrombosis Research Compares
Citation Rate vs Field Avg
+46%
Field avg: 1.56
APC vs Field Avg
+14%
Field avg: $3543

Compared against 11 journals in the same research areas.

ISSN (Print) 0049-3848
ISSN (Online) 1879-2472
Publisher Elsevier BV
Country United States
APC / Cost $4050 USD
In-depth profile & metrics

Thrombosis Research is published by Elsevier BV and based in United States. It runs on a subscription or hybrid model with an article-processing charge of USD 4050.

In our subject taxonomy, Thrombosis Research is classified under Antiplatelet Therapy and Cardiovascular Diseases, Blood Coagulation and Thrombosis Mechanisms, Blood properties and coagulation and Platelet Disorders and Treatments.

Thrombosis Research is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 2.276.

Research Areas
Links
Frequently Asked Questions about Thrombosis Research

Thrombosis Research does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 2.276 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Thrombosis Research is not an open access journal.

The Article Processing Charge (APC) for Thrombosis Research is $4050 USD.

Thrombosis Research is published by Elsevier BV.

Thrombosis Research shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Thrombosis Research is 0049-3848. Its electronic ISSN (eISSN) is 1879-2472.

Thrombosis Research sits in the Q2 quartile based on its latest impact factor of 2.28, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
2.276
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 2.276 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S134546602

Get weekly updates for Antiplatelet Therapy and Cardiovascular Diseases journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google